Alexion Pharmaceuticals (ALXN) PT Raised to $122 at Jefferies Following 3Q
Tweet Send to a Friend
Jefferies raised its price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $122.00 (from $121.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
